Federal restrictions seemed to explain why many doctors weren't prescribing medication for opioid addiction. But some caution that removing those rules isn't enough to overcome hesitancy and stigma.

When a dire disease strikes, it's easy to slip into war terms to describe the experience. But that sort of talk turns life into two outcomes: winning and losing. And that's not the way life works.

Archaeologists have discovered evidence of a rare type of skull surgery dating back to the Bronze Age that's similar to a procedure still being used today.

Two stroke patients regained control of a disabled arm and hand after researchers delivered electrical stimulation to their spines, paving the way toward a medical device that could aid movement.

The FDA announced the supply troubles in the fall. Four months later, the medication remains hard to get and could stay that way until the spring

For people with drug-resistant epilepsy, surgery used to be seen as a last resort. Now it's often the treatment of choice.

Dr. Henry Marsh felt comfortable in hospitals — until he was diagnosed with advanced prostate cancer. "I was much less self-assured now that I was a patient myself," he says. His book is And Finally.

The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.

Some companies and researchers think smart computers might eventually help with provider shortages in mental health, and some consumers are already turning to chatbots to build "emotional resilience."

A group of doctors trains health care providers to treat miscarriage in the emergency department. This could be increasingly important in states where abortion is outlawed.

Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.

Testing pregnant people's blood to look at free-floating DNA can tell doctors about the health of the fetus. But these tests sometime turn up DNA that might be shed by cancerous cells.

Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

A new wave of counselors is supporting people of color by 'decolonizing' the practice of therapy. They aim to make therapy more culturally responsive and to take generational trauma into account.